Cowberry leaves (Folia Uvae-ursi)

Pharmacodynamics Pharmacokinetics Indications Carefully Contraindications Dosing and Administration Side effects
Read on
Clinical and pharmacological group: & nbsp

Diuretics

Included in the formulation
  • Cowberry leaves
    powder inwards 
    LEK S +, LLC     Russia
  • Cowberry leaves
    raw materials. inwards 
    LEK S +, LLC     Russia
  • Cowberry leaves
    raw materials. inwards 
    FITO-EM agrarian and industrial firm, CJSC     Russia
  • Cowberry leaves
    raw materials.powder inwards 
    FITOFARM PKF, LLC     Russia
  • Cowberry leaves
    raw materials. inwards 
    MICROGEN FGUP Scientific and Production Association     Russia
  • Cowberry leaves
    raw materials. inwards 
    FITOFARM PKF, LLC     Russia
  • Cowberry leaves
    raw materials. inwards 
    St.-MEDIFARM, CJSC     Russia
  • Cowberry leaves
    powderraw materials. inwards 
    St.-MEDIFARM, CJSC     Russia
  • Cowberry leaves
    powderraw materials. inwards 
    KRASNOHORSKILKLEKSSREDSTVA, JSC     Russia
  • Cowberry leaves
    raw materials. inwards 
    KRASNOHORSKILKLEKSSREDSTVA, JSC     Russia
    • АТХ:

    G.04.B.X   Other drugs for the treatment of urological diseases

    Pharmacodynamics:

    A plant-derived preparation that exerts choleretic, diuretic, anti-inflammatory and antimicrobial, astringent and demineralizing action. It is active against Staphylococcus aureus, intensifies the action of antibiotics, stimulates phagocytosis, regulates nitrogen metabolism.

    Pharmacokinetics:No data.
    Indications:

    Pyelonephritis, prostatitis, gonorrhea; aboutan intimate syndrome; nephropathy of pregnant women; stones in the kidneys; arthritis and spondylosis; pneumonia, bronchiectasis, bronchitis; parodontosis,stomatitis, gingivitis, ulcerative lesions of the oral mucosa; tonsillitis; gastritis with reduced secretion of hydrochloric acid and hepatitis.

    ICD-10

    I.A50-A64.A54   Gonococcal infection

    X.J00-J06.J03   Acute tonsillitis

    X.J10-J18.J15   Bacterial pneumonia, not elsewhere classified

    X.J20-J22.J20   Acute bronchitis

    X.J30-J39.J35.0   Chronic tonsillitis

    X.J40-J47.J42   Chronic bronchitis, unspecified

    X.J40-J47.J47   Bronchoectasia

    XI.K00-K14.K05   Gingivitis and periodontal disease

    XI.K00-K14.K12   Stomatitis and related lesions

    XI.K20-K31.K29   Gastritis and duodenitis

    XI.K70-K77.K73   Chronic hepatitis, not elsewhere classified

    XIII.M00-M03.M02   Reactive arthropathy

    XIII.M05-M14.M05   Seropositive rheumatoid arthritis

    XIII.M45-M49.M47   Spondylosis

    XIV.N00-N08.N04   Nephrotic syndrome

    XIV.N10-N16.N10   Acute tubulointerstitial nephritis

    XIV.N10-N16.N11   Chronic tubulointerstitial nephritis

    XIV.N20-N23.N20   Kidney and ureter stones

    XIV.N20-N23.N21   Stones of the lower parts of the urinary tract

    XIV.N30-N39.N30   Cystitis

    XIV.N30-N39.N34   Urethritis and urethral syndrome

    Contraindications:Individual intolerance.
    Carefully:No data.
    Pregnancy and lactation:No data.
    Dosing and Administration:

    Inside, inhalation, for rinses in the form of infusion and broth (1:10). With edematic syndrome, 15-30 ml is prescribed 3-4 times a day.

    Side effects:Allergic reactions.
    Overdose:No data.
    Interaction:No data.
    Special instructions:No data.
    Instructions
    Up